Cargando…
Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765]
Autor principal: | Ramaiah, Mekala Janaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883700/ https://www.ncbi.nlm.nih.gov/pubmed/33615040 http://dx.doi.org/10.1016/j.genrep.2021.101054 |
Ejemplares similares
-
mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19
por: Ramaiah, Mekala Janaki
Publicado: (2020) -
Corrigendum to “Joint prevalence of physical activity and sitting time during COVID-19 among US adults in April 2020” [Prev. Med. Rep. 20 (2020) 101256]
por: Meyer, Jacob, et al.
Publicado: (2021) -
Corrigendum to “The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients” [Kidney Int. Rep. 2020 1416–1421]
por: Xu, Xin, et al.
Publicado: (2021) -
Corrigendum to “Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries.” Kidney Int Rep. 2020;5:263–277
Publicado: (2020) -
Corrigendum to “Kimura T, Snijder R, Nozaki K. Diagnosis patterns of CKD and anemia in the Japanese population.” Kidney Int. Rep. 2020;5:694–705
Publicado: (2020)